<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Flaig Highlights Key NCCN Clinical Practice Guidelines Updates for Bladder Cancer

by The ASCO Post | May 15, 2025
placeholder

Thomas W. Flaig, MD, University of Colorado Cancer Center member, presented critical updates to the NCCN Clinical Practice Guidelines in Oncology at the 30th Annual Conference. His insights focused on new treatment strategies for bladder cancer, including novel immunotherapy combinations and revised systemic therapy approaches for muscle-invasive and metastatic disease.

Topics: Press Coverage